findmyKOL

Praveer Jain, MD

Basic profile

ATP Clinical Research

ORCIDNone on fileNPI
RegionEast Stroudsburg, PA · NortheastSpecialtyClinical Cardiac ElectrophysiologyFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2024Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Praveer Jain is a Cardiology physician affiliated with ATP Clinical Research. OpenAlex indexes 14 publications with 505 citations (h-index 6); ClinicalTrials.gov lists 1 registered study matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
14publications

Distinct works indexed by OpenAlex.

505citations

Total citations across indexed works.

6h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials
19companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

500 Plaza Court, Suite A
Pmc Physician Associates Cardiology
East Stroudsburg, PA 183018262

Telephone

570-424-9970

Provider last certified this registry record 9 Oct 2024.

View the NPPES registry record

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Industry payments

19 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    80.1%
    Beta blocker23.2%
    Metoprolol Succinate53%Metoprolol Tartrate21%Carvedilol16%Sotalol8%Atenolol3%
    Part D<11 patients
    Statin18.7%
    Atorvastatin Calcium78%Rosuvastatin Calcium14%Simvastatin8%
    Part D153 patients

    + 15 more classes in this area

  • Blood & clotting

    17.2%
    Factor Xa inhibitor12.9%
    Eliquis75%Xarelto25%
    Part D87 patients
    P2Y12 inhibitor2.6%
    Clopidogrel100%
    Part D26 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    2.7%
    Potassium supplement1.8%
    Potassium Chloride50%Klor-Con M1025%Klor-Con M2025%
    Part D<11 patients
    SGLT2 inhibitor0.9%
    Jardiance100%
    Part D12 patients
Where care is delivered (Part B)18.5% facility · 81.5% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”